Education
About Us
Working with TipRanks
Follow Us
Seres Therapeutics (DE:1S90)
FRANKFURT:1S90
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 126.33M | $ 7.13M | $ 144.93M | $ 33.22M |
| Gross Profit | $ -14.70M | $ 125.62M | $ 6.12M | $ 144.93M | $ -57.35M |
| Operating Income | $ -121.31M | $ -107.98M | $ -246.49M | $ -64.49M | $ -88.13M |
| EBITDA | $ -111.07M | $ -94.31M | $ -237.51M | $ -56.72M | $ -77.31M |
| Net Income | $ 136.00K | $ -113.72M | $ -250.16M | $ -65.58M | $ -89.13M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 30.79M | $ 127.97M | $ 181.34M | $ 290.71M | $ 253.62M |
| Total Assets | $ 139.81M | $ 358.60M | $ 348.78M | $ 354.86M | $ 342.94M |
| Total Debt | $ 91.64M | $ 213.94M | $ 162.59M | $ 49.21M | $ 40.77M |
| Net Debt | $ 60.85M | $ 85.97M | $ -440.00K | $ -130.79M | $ -75.28M |
| Total Liabilities | $ 126.03M | $ 403.46M | $ 338.00M | $ 223.35M | $ 168.19M |
| Stockholders' Equity | $ 13.78M | $ -44.86M | $ 10.78M | $ 131.51M | $ 174.75M |
| Cash Flow | |||||
| Free Cash Flow | $ -148.99M | $ -125.33M | $ -238.64M | $ -2.88M | $ -94.20M |
| Operating Cash Flow | $ -148.61M | $ -117.35M | $ -228.82M | $ 6.69M | $ -93.61M |
| Investing Cash Flow | $ 142.29M | $ 10.58M | $ 82.43M | $ 64.09M | $ -158.89M |
| Financing Cash Flow | $ -90.37M | $ 71.70M | $ 129.60M | $ 1.18M | $ 303.42M |